گزارش درمان شش مورد کولیت اولسروز مقاوم به درمان استاندارد با سیکلوسپرین

Authors

  • انصاری , رضا
  • فاخری , حافظ
  • ملک زاده , رضا
  • میرمجلسی , سید حسین
  • واحدی , محمد
Abstract:

Background and purpose: Treatment of refractory ulcerative colitis (ÜÇ) is a problem in the intestinal tract diseases. Different researches have shown that intravenous administration of cyclosporine before surgical operation can be effective. But less is known about the oral administration of cyclosporine given at the onset of the treatment of refractory ÜÇ. Ïn this study effectiveness and side effects of cyclosporine have been evaluated in the severe case of ÜÇ. Materials and Methods: Four cases of ÜÇ. at severe attack, conformed on the basis of Truelove and wilk criteria were found resistant to steroids, and two patients were dependent to steroids whose disease was not controlled completely and were under our investigation. Two patients received intravenous cyclosporine 4 mg/kg daily for two days and followed by low does of (≤ 5mg/kg daily) oral administration of cyclosporine. The same low doses of oral cyclosporine were administered in four patients at the onset of treatment. Mean duration of treatment was 15.5 weeks. Response to treatment was evaluated on the basis of frequency of defecation, rectorhalgia and colonoscopic appearance. Blood level of cyclosporine in the, 9, 4, 6, 8, 10, 14 and 18 weeks was measured. Âll the patients simultaneously received corticosteroides sulfasulazin 5-ÂSÂ, and patients received Âzathioprine (6MP). Results: The severiarity of disease was decreased after intravenous administration of cyclosporine within 2 months, but one of all six patients was recovered after the administration of low dose of oral cyclosporine. Ôn the basis of statistical analysis there was no apparent recovery in the mean score of variants. Finally after 18 weeks three patients were colectomy, and there was no significant response in 2 patients. Ïn four patients there was side effects of sinusitis, gum hyperplasy severe reduction of libido and increase in keratinin in one patient, tremor was observed in 2 patients. Çonclusion: Ïn our limited experience,low doses of cyclosporine in controlled standard refractory ÜÇ was not effective and was followed by side effects.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

مقایسه تأثیر وضعیت طاق باز و دمر بر وضعیت تنفسی نوزادان نارس مبتلا به سندرم دیسترس تنفسی حاد تحت درمان با پروتکل Insure

کچ ی هد پ ی ش مز ی هن ه و فد : ساسا د مردنس رد نامرد ي سفنت سرتس ي ظنت نادازون داح ي سکا لدابت م ي و نژ د ي سکا ي د هدوب نبرک تسا طسوت هک کبس اـه ي ناـمرد ي فلتخم ي هلمجزا لکتورپ INSURE ماجنا م ي دوش ا اذل . ي هعلاطم ن فدهاب اقم ي هس عضو ي ت اه ي ندب ي عضو رب رمد و زاب قاط ي سفنت ت ي هـب لاتـبم سراـن نادازون ردنس د م ي سفنت سرتس ي لکتورپ اب نامرد تحت داح INSURE ماجنا درگ ...

full text

درمان کاوازاکی مقاوم به درمان؛ گزارش یک مورد

A child with aggressive and resistant Kawasaki disease with coronary aneurysm is described. Despite two doses of immune globulin and high dose of aspirin the patient was treated with the third dose of immune globulin. The patient apparently responded to normalization of symptoms and signs, with no more progression of coronary artery abnormalities.

full text

درمان کاوازاکی مقاوم به درمان؛ گزارش یک مورد

تعداد بسیار کمی از بیماران دچار کاوازاکی به رژیم درمانی استاندارد با ایمونوگلوبین وریدی و آسپرین مقاوم هستند. بیماران مقاوم به درمان استاندارد در معرض خطر کسب عوارض بیش تر بیماری خصوصا ضایعات عروق کرونری قلب می باشند. اگر چه درمان مدون و استاندارد شده ای برای آنان وجود ندارد، درمان سریع تر این بیماران از میزان خطر عوارض قلبی - عروقی در آنان خواهد کاست. هدف این مقاله معرفی یک بیمار با کاوازاکی م...

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 9  issue 25

pages  54- 59

publication date 2000-01

By following a journal you will be notified via email when a new issue of this journal is published.

Keywords

No Keywords

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023